Listing Information

IPO AND SECONDARY MARKET PUBLIC OFFERING

Ibnsina Pharma S.A.E. intends to proceed with an initial public offering on the Egyptian Exchange (the "Offering") that is expected to consist of a primary Offering of newly issued shares and a secondary Offering of existing shares held by the Company’s current shareholders (collectively the “Shares”) constituting up to 38% of Ibnsina Pharma’s total shares. Proceeds from the transaction will be used to grow Ibnsina’s core distribution business and support its expansion into new, higher-margin revenue streams. The Offering is expected to take place in late Q4 2017 or early Q1 2018, subject to market conditions and the receipt of regulatory approvals.